Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) versus conventional chemotherapy with rituximab (CHOP-R) as first-line therapy in 134 high-risk follicular lymphoma patients aged <60 years. The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruna, Riccardo, Benedetti, Fabio, Boccomini, Carola, Patti, Caterina, Barbui, Anna Maria, Pulsoni, Alessandro, Musso, Maurizio, Liberati, Anna Marina, Gini, Guido, Castellino, Claudia, Rossini, Fausto, Ciceri, Fabio, Rota-Scalabrini, Delia, Stelitano, Caterina, Di Raimondo, Francesco, Tucci, Alessandra, Devizzi, Liliana, Zoli, Valerio, Zallio, Francesco, Narni, Franco, Dondi, Alessandra, Parvis, Guido, Semenzato, Gianpietro, Lanza, Francesco, Perrone, Tommasina, Angrilli, Francesco, Billio, Atto, Gueli, Angela, Mantoan, Barbara, Rambaldi, Alessandro, Gianni, Alessandro Massimo, Corradini, Paolo, Passera, Roberto, Ladetto, Marco, Tarella, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821615/
https://www.ncbi.nlm.nih.gov/pubmed/31666344
http://dx.doi.org/10.3324/haematol.2018.209932

Ejemplares similares

Ejemplares similares